HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Cuzzocrea Selected Research

Superoxide Dismutase

12/2001Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
11/2001Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis.
3/2001Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.
1/2001Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Cuzzocrea Research Topics

Disease

33Inflammation (Inflammations)
10/2017 - 02/2000
15Necrosis
03/2011 - 09/2000
14Ischemia
02/2010 - 01/2000
13Reperfusion Injury
02/2023 - 01/2000
13Shock
06/2007 - 01/2000
12Pleurisy (Pleuritis)
10/2010 - 02/2000
9Spinal Cord Injuries (Spinal Cord Injury)
04/2024 - 11/2007
9Lung Injury
10/2010 - 02/2000
8Colitis
11/2008 - 09/2000
8Multiple Organ Failure (MODS)
06/2002 - 03/2000
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2009 - 09/2000
7Experimental Arthritis
11/2008 - 02/2000
6Arthritis (Polyarthritis)
10/2010 - 02/2000
4Edema (Dropsy)
01/2016 - 03/2001
4Body Weight (Weight, Body)
02/2005 - 10/2000
3Neoplasms (Cancer)
09/2022 - 01/2010
3Myelitis
10/2017 - 11/2007
3Alzheimer Disease (Alzheimer's Disease)
03/2016 - 01/2010
3Pneumonia (Pneumonitis)
10/2010 - 07/2001
3Rheumatoid Arthritis
01/2009 - 12/2001
3Periodontitis
02/2007 - 04/2004
3Hemorrhage
12/2002 - 01/2001
3Hemorrhagic Shock
12/2002 - 01/2001
3Peritonitis
06/2002 - 01/2001
3Weight Loss (Weight Reduction)
11/2001 - 09/2000
3Diarrhea
01/2001 - 09/2000
3Brain Injuries (Brain Injury)
11/2000 - 07/2000
2Brain Diseases (Brain Disorder)
01/2022 - 01/2010
2Neuroinflammatory Diseases
01/2020 - 01/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016 - 01/2010
2Wounds and Injuries (Trauma)
01/2009 - 11/2007

Drug/Important Bio-Agent (IBA)

15CarrageenanIBA
01/2016 - 02/2000
14Reactive Oxygen Species (Oxygen Radicals)IBA
01/2010 - 02/2000
12Peroxynitrous Acid (Peroxynitrite)IBA
10/2017 - 01/2000
9MelatoninIBA
04/2024 - 01/2000
93-nitrotyrosineIBA
01/2016 - 08/2000
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009 - 02/2001
8Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2017 - 11/2000
8Peroxidase (Myeloperoxidase)IBA
07/2007 - 02/2000
8tempolIBA
01/2001 - 02/2000
7CytokinesIBA
10/2017 - 10/2001
7EnzymesIBA
06/2013 - 09/2000
7Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2010 - 03/2001
7Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2001 - 06/2000
6Proteins (Proteins, Gene)FDA Link
10/2017 - 01/2010
6Superoxides (Superoxide)IBA
01/2010 - 11/2000
6Interleukin-1beta (Interleukin 1 beta)IBA
10/2009 - 02/2001
6DinitrobenzenesIBA
02/2003 - 09/2000
6Sulfonic AcidsIBA
02/2003 - 09/2000
6Malondialdehyde (Propanedial)IBA
11/2001 - 02/2000
6Ligases (Synthetase)IBA
08/2001 - 04/2000
6Poly Adenosine Diphosphate RiboseIBA
08/2001 - 04/2000
5P-SelectinIBA
10/2009 - 06/2000
5Oxidants (Oxidizing Agents)IBA
01/2008 - 08/2000
5Oxygen (Dioxygen)IBA
01/2008 - 03/2000
5Free RadicalsIBA
01/2008 - 03/2001
52,4-dinitrofluorobenzene sulfonic acidIBA
02/2003 - 09/2000
5ZymosanIBA
06/2002 - 03/2000
5DNA (Deoxyribonucleic Acid)IBA
08/2001 - 09/2000
4Neuroprotective AgentsIBA
01/2020 - 01/2011
4Tyrosine Kinase InhibitorsIBA
06/2016 - 07/2000
4CreatinineIBA
02/2010 - 04/2000
4NitritesIBA
02/2010 - 06/2000
4Hydroxyl RadicalIBA
01/2010 - 03/2001
4Nitric Oxide Synthase (NO Synthase)IBA
04/2004 - 11/2000
4imisopasem manganeseIBA
04/2003 - 02/2001
4Superoxide DismutaseIBA
12/2001 - 01/2001
4Acetylcysteine (Siran)FDA LinkGeneric
07/2001 - 07/2000
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2024 - 10/2010
3NAD (NADH)IBA
01/2022 - 11/2000
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2016 - 02/2008
3Collagen Type II (Type II Collagen)IBA
10/2010 - 12/2000
3Dinoprostone (PGE2)FDA Link
10/2010 - 02/2001
3EmulsionsIBA
10/2010 - 12/2000
3Bleomycin (Blenoxane)FDA LinkGeneric
10/2010 - 02/2005
3Freund's AdjuvantIBA
10/2010 - 12/2000
3Urea (Carbamide)FDA LinkGeneric
02/2010 - 04/2000
3EndotoxinsIBA
11/2008 - 06/2000
3Etanercept (Enbrel)FDA Link
07/2008 - 02/2007
3Inflammation MediatorsIBA
11/2007 - 03/2001
3NitratesIBA
11/2006 - 06/2000
3Interleukin-6 (Interleukin 6)IBA
02/2003 - 02/2001
3CalpainIBA
06/2001 - 12/2000
3acetylleucyl-leucyl-norleucinalIBA
04/2001 - 12/2000
2palmidrolIBA
02/2023 - 01/2016
2LigandsIBA
09/2022 - 03/2011
2AntioxidantsIBA
01/2022 - 03/2001
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2017 - 10/2010
2EicosanoidsIBA
03/2016 - 01/2016
2lipoxin A4IBA
03/2016 - 01/2016
2AcidsIBA
01/2011 - 04/2001
2zileuton (Zyflo)FDA Link
10/2010 - 02/2008
2LipopolysaccharidesIBA
10/2010 - 08/2001
2EstersIBA
10/2010 - 01/2010
2NF-kappa B (NF-kB)IBA
10/2009 - 01/2001

Therapy/Procedure

12Therapeutics
01/2022 - 03/2000
4Laminectomy
10/2017 - 11/2007
3Ligation
02/2007 - 04/2004
3Intradermal Injections
05/2005 - 12/2000
3Resuscitation
12/2002 - 01/2001